Mathematical Model of the Roles of T Cells in Inflammatory Bowel Disease

Bulletin of Mathematical Biology

Volumn 75, Issue 9, 2013, Pages 1417-1433

  Lo, Wing Cheong ^a   Arsenescu, Razvan I ^b   Friedman, Avner ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Cytokines; Inflammatory bowel disease; Mathematical model; T helper cells; Treg control

Indexed keywords

CYTOKINE; TRANSCRIPTION FACTOR;

ARTICLE; BIOLOGICAL MODEL; BIOLOGY; HUMAN; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASE; INTESTINE MUCOSA; MATHEMATICAL PHENOMENA; METABOLISM; MUCOSAL IMMUNITY; SYSTEMS BIOLOGY; T LYMPHOCYTE SUBPOPULATION;

COMPUTATIONAL BIOLOGY; CYTOKINES; HUMANS; IMMUNITY, MUCOSAL; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MATHEMATICAL CONCEPTS; MODELS, IMMUNOLOGICAL; SYSTEMS BIOLOGY; T-LYMPHOCYTE SUBSETS; TRANSCRIPTION FACTORS;

EID: 84883760514     PISSN: 00928240     EISSN: 15229602     Source Type: Journal    
DOI: 10.1007/s11538-013-9853-2     Document Type: Article

References (39)

1. Abraham, C., & Cho, J. H. (2009). Inflammatory bowel disease. N. Engl. J. Med., 361, 2066-2078.
2. Babyatsky, M. W., Rossiter, G., & Podolsky, D. K. (1996). Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease. Gastroenterology, 110, 975-984.
3. Bamias, G., Kaltsa, G., & Ladas, S. D. (2011). Cytokines in the pathogenesis of ulcerative colitis. Discov. Medicin., 11, 459-467.
4. Baumgart, D., & Carding, S. (2007). Inflammatory bowel disease: cause and immunobiology. Lancet, 369(9573), 1627-1640.
5. Bouma, G., & Strober, W. (2003). The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol., 3(7), 521-533.
6. Conlon, P. J., Tyler, S., Grabstein, K. H., & Morrissey, P. (1989-1990) Interleukin-4 (b-cell stimulatory factor-1) augments the in vivo generation of cytotoxic cells in immunosuppressed animals. Biotechnol. Ther., 1, 31-41.
7. Cosmi, L., Liotta, F., Angeli, R., Mazzinghi, B., Santarlasci, V., Manetti, R., Lasagni, L., Vanini, V., Romagnani, P., Maggi, E., Annunziato, F., & Romagnani, S. (2004). Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines. Blood, 103, 3117-3121.
8. Czarniecki, C. W., & Sonnenfeld, G. (1993). Interferon-gamma and resistance to bacterial infections. APMIS, Acta Pathol. Microbiol. Immunol. Scand., 101, 1-17.
9. Eastaff-Leung, N., Mabarrack, N., Barbour, A., Cummins, A., & Barry, S. (2010). Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J. Clin. Immunol., 30, 80-89.
10. Germain, R. N. (2012). Maintaining system homeostasis: the third law of Newtonian immunology. Nat. Immunol., 13, 902-906.
11. Grassegger, A., & Hopf, R. (2004). Significance of the cytokine interferon gamma in clinical dermatology. Clin. Exp. Dermatol., 29, 584-588.
12. Grogan, J. L., Mohrs, M., Harmon, B., Lacy, D. A., Sedat, J. W., & Locksley, R. M. (2001). Early transcription and silencing of cytokine genes underlie polarization of t helper cell subsets. Immunity, 14(3), 205-215.
13. Gross, F., Metzner, G., & Behn, U. (2010). Mathematical modeling of allergy and specific immunotherapy: Th1-Th2-Treg interactions. J. Theor. Biol., 269, 70-78.
14. Hofer, T., Nathansen, H., Lohning, M., Radbruch, A., & Heinrich, R. (2002). GATA-3 transcriptional imprinting in Th2 lymphocytes: a mathematical model. Proc. Natl. Acad. Sci. USA, 99, 9364-9368.
15. Hwang, E. S., Hong, J. H., & Glimcher, L. H. (2005). IL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508. J. Exp. Med., 202, 1289-1300.
16. Ishikawa, D., Okazawa, A., Corridoni, D., Jia, L. G., Wang, X. M., Guanzon, M., Xin, W., Arseneau, K. O., Pizarro, T. T., & Cominelli, F. (2012). Tregs are dysfunctional in vivo in a spontaneous murine model of Crohn's disease. Mucosal Immunol. doi: 10. 1038/mi. 2012. 67.
17. Kaminskam, B., Wesolowska, A., & Danilkiewicz, M. (2005). Tgf beta signalling and its role in tumour pathogenesis. Acta Biochim. Pol., 52, 329-337.
18. Kato, K., Fukunaga, K., Kamikozuru, K., Kashiwamura, S., Hida, N., Ohda, Y., Takeda, N., Yoshida, K., Iimuro, M., Yokoyama, Y., Kikuyama, R., Miwa, H., & Matsumoto, T. (2011). Infliximab therapy impacts the peripheral immune system of immunomodulator and corticosteroid naive patients with Crohn's disease. Gut Liver, 5, 37-45.
19. Kugathasan, S., Saubermann, L. J., Smith, L., Kou, D., Itoh, J., Binion, D. G., Levine, A. D., Blumberg, R. S., & Fiocchi, C. (2007). Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease. Gut, 56, 1696-1705.
20. Lee, S.-M., Gao, B., & Fang, D. (2008). Foxp3 maintains Treg unresponsiveness by selectively inhibiting the promoter DNA-binding activity of AP-1. Blood, 111(7), 3599-3606.
21. Lighvani, A. A., Frucht, D. M., Jankovic, D., Yamane, H., Aliberti, J., Hissong, B. D., Nguyen, B. V., Gadina, M., Sher, A., Paul, W. E., & O'Shea, J. J. (2001). T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc. Natl. Acad. Sci. USA, 98(15), 137-142.
22. Maloy, K., & Powrie, F. (2011). Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature, 474(7351), 298-306.
23. Matsuoka, K., Inoue, N., Sato, T., Okamoto, S., Hisamatsu, T., Kishi, Y., Sakuraba, A., Hitotsumatsu, O., Ogata, H., Koganei, K., Fukushima, T., Kanai, T., Watanabe, M., Ishii, H., & Hibi, T. (2004). T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease. Gut, 53, 1303-1308.
24. Maul, J., Loddenkemper, C., Mundt, P., Berg, E., Giese, T., Stallmach, A., Zeitz, M., & Duchmann, R. (2005). Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology, 128, 1868-1878.
25. Mitsuyama, K., Tomiyasu, N., Takaki, K., Masuda, J., Yamasaki, H., Kuwaki, K., Takeda, T., Kitazaki, S., Tsuruta, O., & Sata, M. (2006). Interleukin-10 in the pathophysiology of inflammatory bowel disease: increased serum concentrations during the recovery phase. Mediat. Inflamm., 2006(6), 26875.
26. Nelson, B. H. (2004). IL-2, regulatory T cells, and tolerance. J. Immunol., 172, 3983-3988.
27. Osugi, Y., Hara, J., Tagawa, S., Takai, K., Hosoi, G., Matsuda, Y., Ohta, H., Fujisaki, H., Kobayashi, M., Sakata, N., Kawa-Ha, K., Okada, S., & Tawa, A. (1997). Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood, 89, 4100-4103.
28. Pak, S., Holland, N., Garnett, E. A., Mileti, E., Mahadevan, U., Beckert, R., Kanwar, B., & Heyman, M. B. (2012). Cytokine profiles in peripheral blood of children and adults with Crohn disease. J. Pediatr. Gastroenterol. Nutr., 54, 769-775.
29. Rao, B. M., Driver, I., Lauffenburger, D. A., & Wittrup, K. D. (2004). Interleukin 2 (IL-2) variants engineered for increased IL-2 receptor alpha-subunit affinity exhibit increased potency arising from a cell surface ligand reservoir effect. Mol. Pharmacol., 66, 864-869.
30. Robinson, T. M., Nelson, R. G., & Boyer, J. D. (2003). Parasitic infection and the polarized Th2 immune response can alter a vaccine-induced immune response. DNA Cell Biol., 22, 421-430.
31. Rubin, D. T., Uluscu, O., & Sederman, R. (2012). Response to biologic therapy in Crohn's disease is improved with early treatment: An analysis of health claims data. Inflamm. Bowel Dis. doi: 10. 1002/ibd. 22925.
32. Sakaguchi, S., Wing, K., & Yamaguchi, T. (2009). Dynamics of peripheral tolerance and immune regulation mediated by Treg. Eur. J. Immunol., 39, 2331-2336.
33. Sansonetti, P. J. (2004). War and peace at mucosal surfaces. Nat. Rev. Immunol., 4, 953-964.
34. Stummvoll, G. H., DiPaolo, R. J., Huter, E. N., Davidson, T. S., Glass, D., Ward, J. M., & Shevach, E. M. (2008). Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells. J. Immunol., 181(3), 1908-1916.
35. Szabo, S. J., Dighe, A. S., Gubler, U., & Murphy, K. M. (1997). Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med., 185(5), 817-824.
36. Wendelsdorf, K., Bassaganya-Riera, J., Hontecillas, R., & Eubank, S. (2010). Model of colonic inflammation: immune modulatory mechanisms in inflammatory bowel disease. J. Theor. Biol., 264, 1225-1239.
37. Yates, A., Callard, R., & Stark, J. (2004). Combining cytokine signalling with T-bet and GATA-3 regulation in Th1 and Th2 differentiation: a model for cellular decision-making. J. Theor. Biol., 231(2), 181-196.
38. Zenewicz, L. A., Antov, A., & Flavell, R. A. (2009). CD4 T-cell differentiation and inflammatory bowel disease. Trends Mol. Med., 15(5), 199-207.
39. Zhu, J., Jankovic, D., Oler, A., Wei, G., Sharma, S., Hu, G., Guo, L., Yagi, R., Yamane, H., Punkosdy, G., Feigenbaum, L., Zhao, K., & Paul, W. E. (2012). The transcription factor T-bet is induced by multiple pathways and prevents an endogenous Th2 cell program during Th1 cell responses. Immunity, 37, 660-673.